- Differential Diagnosis
- Try building your search one term at a time, and be as specific as you can! Search term example: "chronic cough".
- Do not enter multiple findings such as "anemia, chronic cough, weight loss, vomiting" all at the same time.
- After selecting your term from the search results a list of possible diagnoses will be generated. If the list is too long, you will be able to narrow it down by entering additional terms.
- Do not enter values such as "heart rhythm 110" or "sodium 125", instead use "tachycardia" or "hyponatremia".
Drug Information for VALPROIC ACID SYRUP (Valproic Acid Oral Solution, USP) 250 mg/5 mL (Morton Grove Pharmaceuticals, Inc.): OVERDOSAGE
- INDICATIONS AND USAGE
- ADVERSE REACTIONS
- DOSAGE AND ADMINISTRATION
- HOW SUPPLIED
- Patient Information Leaflet
- Diseases/Conditions Related to VALPROIC ACID SYRUP (Valproic Acid Oral Solution, USP) 250 mg/5 mL (Morton Grove Pharmaceuticals, Inc.)
- External Links Related to VALPROIC ACID SYRUP (Valproic Acid Oral Solution, USP) 250 mg/5 mL (Morton Grove Pharmaceuticals, Inc.)
Overdosage with valproate may result in somnolence, heart block, and deep coma. Fatalities have been reported; however, patients have recovered from valproate levels as high as 2120 mcg/mL.
In overdose situations, the fraction of drug not bound to protein is high and hemodialysis or tandem hemodialysis plus hemoperfusion may result in significant removal of drug. The benefit of gastric lavage or emesis will vary with the time since ingestion. General supportive measures should be applied with particular attention to the maintenance of adequate urinary output.
Naloxone has been reported to reverse the CNS depressant effects of valproate overdosage. Because naloxone could theoretically also reverse the antiepileptic effects of valproate, it should be used with caution in patients with epilepsy.
- Drug Information Provided by National Library of Medicine (NLM).